Results 221 to 230 of about 76,424 (294)

Prolonged Tardive Dyskinesia Induced by Long-Acting Paliperidone Palmitate in Schizophrenia: A Case Report. [PDF]

Am J Case Rep
Chen YM, Chang S.
europepmc   +1 more source

Clozapine protects bone mineral density in female patients with schizophrenia [PDF]

, 2011
Chieh‐Hsin Lin, Kuo-Hao Huang, Yue‐Cune Chang, Yichen Huang, Wan-Chih Hsu, Chun-Yuan Lin, Frank Huang‐Chih Chou, Guochuan Tsai, Hsien‐Yuan Lane   +8 more
openalex   +1 more source

Investigating of the Experience of Subjective Well-Being of Clozapine Use in Patients with Treatment-Resistant Schizophrenia: A Mixed Method Study. [PDF]

Patient Prefer Adherence
Khazaie H, Rezaie L.
europepmc   +1 more source

Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activityviacalmodulin kinase II–NMDA receptor interactions [PDF]

, 2011
Sudarshana Purkayastha, Jason Ford, Baishali Kanjilal, Souleymane Diallo, Joseph Del Rosario Inigo, Lorenz S. Neuwirth, Abdeslem El Idrissi, Zaghloul Ahmed, Andrzej Wieraszko, Efrain C. Azmitia, Probal Banerjee   +10 more
openalex   +1 more source

A multidisciplinary approach to establishing clozapine in a patient with schizophrenia and comorbid ASD: a case report. [PDF]

BMC Psychiatry
Bridges M, Secchi A, Whiskey E, Shergill S.   +3 more
europepmc   +1 more source

Formulation & In-Vitro Evaluation of Clozapine Nanosuspension

Lavanya Muppidi, Dr. A M. Manoranjani*
openalex   +1 more source

Clozapine Drug-Drug Interactions and Individualized Dosing in Bipolar Disorder: A Model-Informed Precision Dosing Approach. [PDF]

Drug Des Devel Ther
Zhang Y, Wang J, Tian X, Zhang YJ, Li Y, He SM, Zhang C, Chen X, Wang DD.   +8 more
europepmc   +1 more source

Individual Differences in The Pharmacokinetics of Clozapine in Healthy Chinese Adults [PDF]

, 2012
Yiping Liu, LI Huan-de, Miao Yan
openalex   +1 more source

Clozapine as an Off‐Severe and Treatment‐Resistant (Auto‐)Aggressive Label Treatment for Behavior in a 40‐Year‐Old Patient With Mild Intellectual Disability and Borderline Personality Disorder

Case Reports in Psychiatry, Volume 2026, Issue 1, 2026.
Background Clozapine has shown to be effective as an off‐label treatment for aggressive behavior in patients with borderline personality disorder (BPD) and mild intellectual disability (MID). However, there is a lack of empirical evidence for its efficacy in these patient populations and results are so far heterogeneous. Case Presentation A 40‐year‐old
Lukas Zabel, Nathalie Ersek, Andreas B. Hofmann, Lena Machetanz, Johannes Kirchebner, Susanne Stübner, Erik Jönsson   +6 more
wiley   +1 more source

Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report

, 2018
Domenico De Berardis, Michele Fornaro, Laura Orsolini, Luigi Olivieri, Francesco Nappi, Gabriella Rapini, Federica Vellante, Cosimo Napoletano, Nicola Serroni, Massimo Di Giannantonio   +9 more
openalex   +2 more sources